Internal Medicine, Infectious Disease · Philadelphia, PA
NPI
1265571152
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1233 Locust St Fl 4
Philadelphia, PA, 19107
Phone (215) 790-1788
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$5.7M
6,802 prescriptions
Company payments, 2025
$117K
From 7 companies
Medicare prescription drug claims, 2024
In 2024, the drug Karam C Mounzer prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 352 prescriptions and refills. In total Karam C Mounzer wrote 6,802 Medicare prescriptions that cost $5.7M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 352 | 354 | 46 | $1.4M |
| Tivicay Dolutegravir Sodium | 239 | 255 | 27 | $631K |
| Atorvastatin Calcium Generic | 230 | 292 | 35 | $1,301 |
| Valacyclovir Valacyclovir Hcl | 203 | 231 | 27 | $6,224 |
| Descovy Emtricitabine/Tenofov Alafenam | 200 | 208 | 20 | $443K |
| Rosuvastatin Calcium Generic | 179 | 211 | 27 | $1,273 |
| Gabapentin Generic | 174 | 181 | 24 | $1,123 |
| Amlodipine Besylate Generic | 162 | 200 | 29 | $549 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 119 | 125 | 13 | $497K |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 111 | 136 | 16 | $934 |
| Omeprazole Generic | 107 | 134 | 17 | $590 |
| Dovato Dolutegravir Sodium/Lamivudine | 107 | 107 | 15 | $323K |
| Prezcobix Darunavir/Cobicistat | 102 | 110 | 12 | $268K |
| Maraviroc Generic | 100 | 100 | Under 11 | $99K |
| Darunavir Generic | 96 | 102 | 11 | $93K |
Brand drugs: 2,315 claims; generic drugs: 4,411 claims; opioid claims: 77.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Karam C Mounzer $117K ($117K in general payments such as food, travel and fees) from 7 companies. The largest payer was Gilead Sciences, Inc. with $59K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.